Pharmacological Treatment of Congenital Nystagmus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN65414827

Enrollment

Registered

2003-09-12

Start date

2004-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nystagmus Eye Diseases Nystagmus

Interventions

Administration of gabapentin, memantine or a placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Congenital nystagmus 2. Over 18 years of age

Exclusion criteria

Exclusion criteria: 1. Other neurological condition 2. Pregnancy or breastfeeding 3. Unable or unwilling to give consent

Design outcomes

Primary

Measure	Time frame
Visual acuity	—

Secondary

Measure	Time frame
Nystagmus amplitude	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026